MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Position in ONC — BeOne Medicines Ltd.

CIK 912938 Boston, MA

Position in ONC

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$2,329,629

+$8,809 QoQ

Shares Held

8,175

+4.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#93

of 282 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 2% Shared 98% None 0%

Healthcare · as of Jun 30, 2026

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $2,249,676,327 across 65 Biotechnology names. ONC ranks #29 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	1,875,301	$500,180,281
2	RVMD	Revolution Medicines, Inc.	2,012,317	$376,866,725
3	VRTX	Vertex Pharmaceuticals Inc / Ma	423,049	$210,141,127
4	TECH	BIO-TECHNE Corp	2,746,462	$194,037,538
5	SRRK	Scholar Rock Holding Corp	2,607,348	$143,404,140
6	LGND	Ligand Pharmaceuticals Inc	375,762	$118,774,610
7	ALNY	Alnylam Pharmaceuticals, Inc.	350,560	$105,529,075
8	BNTX	BioNTech SE	677,708	$63,060,728

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,329,629	8,175	+4.6%	Shares	Sole	2026-08-03
2026-03-31	$2,320,820	7,815	+4.3%	Shares	Sole	2026-05-14
2025-12-31	$2,277,054	7,495	+5.6%	Shares	Sole	2026-01-22
2025-09-30	$2,417,265	7,095	-17.6%	Shares	Sole	2025-10-29
2025-06-30	$2,085,190	8,614	-44.8%	Shares	Sole	2025-08-08
2025-03-31	$4,251,022	15,619	-44.1%	Shares	Sole	2025-05-02
2024-12-31	$5,157,656	27,923	+135.2%	Shares	Sole	2025-02-12
2024-09-30	$2,665,831	11,874	—	Shares	Sole	2024-11-12
No filing history on record for this holder in this stock.